The NIPA Study Naloxegol Administration to Prevent Opioids Induced Gastrointestinal Motility Disturbance in Brain Injured PAtients
Clinical trial NCT05008926 · SUSPENDED
Trial details
- NCT number
- NCT05008926
- Sponsor
- University Hospital, Brest
- Status
- SUSPENDED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-15
- Primary completion
- 2027-10-26
- Enrollment
- 370
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.